GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Essex Bio-Technology Ltd (HKSE:01061) » Definitions » EPS (Diluted)

Essex Bio-Technology (HKSE:01061) EPS (Diluted) : HK$0.53 (TTM As of Dec. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Essex Bio-Technology EPS (Diluted)?

Essex Bio-Technology's Earnings per Share (Diluted) for the six months ended in Dec. 2024 was HK$0.26. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.53.

Essex Bio-Technology's EPS (Basic) for the six months ended in Dec. 2024 was HK$0.26. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.54.

Essex Bio-Technology's EPS without NRI for the six months ended in Dec. 2024 was HK$0.28. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.55.

During the past 12 months, Essex Bio-Technology's average EPS without NRIGrowth Rate was 18.70% per year. During the past 3 years, the average EPS without NRIGrowth Rate was -4.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was 2.50% per year. During the past 10 years, the average EPS without NRI Growth Rate was 13.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Essex Bio-Technology's highest 3-Year average EPS without NRI Growth Rate was 55.40% per year. The lowest was -7.60% per year. And the median was 27.30% per year.


Essex Bio-Technology EPS (Diluted) Historical Data

The historical data trend for Essex Bio-Technology's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Essex Bio-Technology EPS (Diluted) Chart

Essex Bio-Technology Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.37 0.58 0.38 0.47 0.53

Essex Bio-Technology Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.29 0.18 0.27 0.26

Competitive Comparison of Essex Bio-Technology's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Essex Bio-Technology's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Essex Bio-Technology's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Essex Bio-Technology's PE Ratio distribution charts can be found below:

* The bar in red indicates where Essex Bio-Technology's PE Ratio falls into.


;
;

Essex Bio-Technology EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Essex Bio-Technology's Diluted EPS for the fiscal year that ended in Dec. 2024 is calculated as

Diluted EPS (A: Dec. 2024 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(307.222-0)/582.320
=0.53

Essex Bio-Technology's Diluted EPS for the quarter that ended in Dec. 2024 is calculated as

Diluted EPS (Q: Dec. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(149.782-0)/571.668
=0.26

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Essex Bio-Technology  (HKSE:01061) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Essex Bio-Technology EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Essex Bio-Technology's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Essex Bio-Technology Business Description

Traded in Other Exchanges
N/A
Address
No. 88, Keji 6th Road, Hi-Tech Zone, Guangdong, Zhuhai, CHN
Essex Bio-Technology Ltd is principally engaged in investment holding and development, manufacture and sale of biologic drugs in the People's Republic of China. The company is made up of segments of Ophthalmology products and Surgical products. Its products under Ophthalmology include the Beifushu series, Tobramycin Eye Drops, Levofloxacin Eye Drops, Sodium Hyaluronate Eye Drops. The products under Surgical include the Beifuji series, Carisolv dental caries removal gel and mouth wash. The majority of the groups revenue comes from PRC.
Executives
Lauw Hui Kian
Ngiam Mia Je Patrick
Ngiam Mia Kiat Benjamin 2101 Beneficial owner

Essex Bio-Technology Headlines

No Headlines